Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| HZNP | Horizon Therapeutics Plc | 2.25% | 93.51 | 5.5% | $179.67m | |
| VRX | Valeant Pharmaceuticals International, Inc. | 0.13% | 30.30 | 14.1% | $178.29m | |
| ICLR | ICON plc | 4.47% | 205.20 | 4.2% | $131.92m | |
| CTLT | Catalent, Inc. | 1.02% | 111.03 | 2.1% | $128.45m | |
| GWPH | GW Pharmaceuticals Plc | 0.21% | 218.81 | 6.1% | $124.34m | |
| BHC | Bausch Health Cos., Inc. | 0.13% | 30.30 | 0.0% | $108.60m | |
| UTHR | United Therapeutics Corp. | -0.55% | 201.67 | 14.1% | $97.68m | |
| JAZZ | Jazz Pharmaceuticals Plc | 1.21% | 168.39 | 2.3% | $90.22m | |
| SAVA | Cassava Sciences, Inc. | -1.63% | 35.09 | 0.0% | $67.46m | |
| ARGX | argenx SE | 1.72% | 277.47 | 0.0% | $51.25m | |
| PRGO | Perrigo Co. Plc | 1.94% | 41.17 | 6.9% | $37.55m | |
| SAGE | SAGE Therapeutics, Inc. | -0.23% | 75.50 | 7.6% | $37.53m | |
| AMRN | Amarin Corp. Plc | -1.96% | 5.01 | 1.5% | $29.35m | |
| PCRX | Pacira Biosciences, Inc. | -4.45% | 66.34 | 9.9% | $27.57m | |
| ICPT | Intercept Pharmaceuticals, Inc. | -4.02% | 20.55 | 16.8% | $22.11m |
Company Profile
GW Pharmaceuticals Plc operates as a biopharmaceutical company. The firm engages in the discovery, development and commercialization of novel therapeutics. It offers its cannabinoid product, Epidiolex oral solution CV, a pharmaceutical formulation of cannabidiol (CBD) focusing on the treatment of seizures associated with tuberous sclerosis complex. The company was founded by Geoffrey William Guy and Brian Whittle in 1998 and is headquartered in Cambridge, the United Kingdom.